Bharat Biotech completes trials for India’s first intranasal Covid vaccine, says it’s safe, immunogenic
By Express News Service HYDERABAD: City-based Bharat Biotech on Monday announced it had completed clinical development for phase III trials…
By Express News Service HYDERABAD: City-based Bharat Biotech on Monday announced it had completed clinical development for phase III trials…